Rational therapy of mixed dyslipidaemia in a patient with diabetes

Charles Reasner

doi:10.1177/14746514070070010501

Rational therapy of mixed dyslipidaemia in a patient with diabetes

Charles Reasner

Medicine

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

Diabetic dyslipidaemia refers to the triad of elevated levels of triglycerides and small, dense LDL-C particles and low levels of HDL-C. These lipid abnormalities are largely responsible for the increased risk of cardiovascular complications in patients with diabetes. This case study outlines a rational approach to the treatment of each of these lipid abnormalities and emphasises the importance of both lowering the LDL-C and raising the HDL-C in high-risk individuals. Combination drug therapy will often be necessary to achieve treatment goals in these patients.

Original language	English (US)
Pages (from-to)	25-30
Number of pages	6
Journal	British Journal of Diabetes and Vascular Disease
Volume	7
Issue number	1
DOIs	https://doi.org/10.1177/14746514070070010501
State	Published - Jan 1 2007

Keywords

Atherogenic dyslipidaemia
Diabetes
Diabetic dyslipidaemia
Fibrates
Niacin
Statins

ASJC Scopus subject areas

Internal Medicine
Endocrinology, Diabetes and Metabolism
Cardiology and Cardiovascular Medicine

Access to Document

10.1177/14746514070070010501

Fingerprint Dive into the research topics of 'Rational therapy of mixed dyslipidaemia in a patient with diabetes'. Together they form a unique fingerprint.

Cite this

@article{f4d92dbb7bce4cf6b4f7f301055c2867,

title = "Rational therapy of mixed dyslipidaemia in a patient with diabetes",

abstract = "Diabetic dyslipidaemia refers to the triad of elevated levels of triglycerides and small, dense LDL-C particles and low levels of HDL-C. These lipid abnormalities are largely responsible for the increased risk of cardiovascular complications in patients with diabetes. This case study outlines a rational approach to the treatment of each of these lipid abnormalities and emphasises the importance of both lowering the LDL-C and raising the HDL-C in high-risk individuals. Combination drug therapy will often be necessary to achieve treatment goals in these patients.",

keywords = "Atherogenic dyslipidaemia, Diabetes, Diabetic dyslipidaemia, Fibrates, Niacin, Statins",

author = "Charles Reasner",

year = "2007",

month = jan,

day = "1",

doi = "10.1177/14746514070070010501",

language = "English (US)",

volume = "7",

pages = "25--30",

journal = "British Journal of Diabetes and Vascular Disease",

issn = "1474-6514",

publisher = "SAGE Publications Inc.",

number = "1",

}

TY - JOUR

T1 - Rational therapy of mixed dyslipidaemia in a patient with diabetes

AU - Reasner, Charles

PY - 2007/1/1

Y1 - 2007/1/1

N2 - Diabetic dyslipidaemia refers to the triad of elevated levels of triglycerides and small, dense LDL-C particles and low levels of HDL-C. These lipid abnormalities are largely responsible for the increased risk of cardiovascular complications in patients with diabetes. This case study outlines a rational approach to the treatment of each of these lipid abnormalities and emphasises the importance of both lowering the LDL-C and raising the HDL-C in high-risk individuals. Combination drug therapy will often be necessary to achieve treatment goals in these patients.

AB - Diabetic dyslipidaemia refers to the triad of elevated levels of triglycerides and small, dense LDL-C particles and low levels of HDL-C. These lipid abnormalities are largely responsible for the increased risk of cardiovascular complications in patients with diabetes. This case study outlines a rational approach to the treatment of each of these lipid abnormalities and emphasises the importance of both lowering the LDL-C and raising the HDL-C in high-risk individuals. Combination drug therapy will often be necessary to achieve treatment goals in these patients.

KW - Atherogenic dyslipidaemia

KW - Diabetes

KW - Diabetic dyslipidaemia

KW - Fibrates

KW - Niacin

KW - Statins

UR - http://www.scopus.com/inward/record.url?scp=33947215569&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947215569&partnerID=8YFLogxK

U2 - 10.1177/14746514070070010501

DO - 10.1177/14746514070070010501

M3 - Article

AN - SCOPUS:33947215569

VL - 7

SP - 25

EP - 30

JO - British Journal of Diabetes and Vascular Disease

JF - British Journal of Diabetes and Vascular Disease

SN - 1474-6514

IS - 1

ER -

Rational therapy of mixed dyslipidaemia in a patient with diabetes

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this